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A B S T R A C TObjectives: The prevalence of dementia in China is among the high-
est in the world, but systematic estimates of the rate of dementia
subtypes and characterization of associated deficits are lacking. The
primary aim of this study was to determine the clinical presentation
of dementia and describe the caregiver burden in mainland China.
Methods: A 3-month, open-enrollment, multicenter, cross-sectional
study was conducted at 48 tier-3 hospitals. Caregivers who qualified
for study entry (provided amount and duration of care information),
had intimate knowledge of patient status, and accompanied enrolled
patients to study sites were asked to participate in an interview about
patient care and caregiver burden. Caregiver burden was assessed via
the Chinese version of the validated Zarit Burden Interview. Results:
A total of 1425 caregivers completed the survey. Patients had mild
to moderate dementia (mean Clinical Dementia Rating score of
1.67  0.79), and the most common dementia subtypes were Alzheimersee front matter Copyright & 2013, International
r Inc.
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pondence to: Boxiong Tang, Pfizer Inc., 235 East 4disease (46.7%) and vascular dementia (28.7%). Among caregivers, 57%
were females, 52% were patients’ spouses, and 67.3% had been caring
for patients for 1 year or more. Most patients required family help and
lived at home or with a family member. Caregiver awareness of
dementia was limited. The mean total caregiver Zarit Burden Inter-
view score was 26.6. Observations were similar across age, gender,
education, dementia type, Clinical Dementia Rating score, and dura-
tion of care. Conclusions: China faces multiple obstacles in preparing
to care for its fast-growing dementia population. Better understanding
of patients and caregivers may mitigate these challenges by improv-
ing awareness and education.
Keywords: caregiver burden, China, cross-sectional studies, dementia.
Copyright & 2013, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Dementia is a typically progressive disease characterized by
cognitive, functional, and/or behavioral deficits. The most well-
known and common subtype of dementia is Alzheimer disease
(AD); other subtypes include vascular dementia (VaD), Lewy body
dementia, and frontotemporal dementia. In 2010, it was esti-
mated that 35.6 million people worldwide suffer from dementia
[1]. By 2030, approximately 65.7 million people will be living with
dementia; and by 2050, the number is expected to increase to
115.4 million [1].
One country most likely to be impacted by the growing burden
of dementia is China. In addition to having the largest population
in the world, China has the fastest growing elderly population [2].
It is established that dementia primarily affects older patients,
and the risk of developing dementia approximately doubles every
5 years after the age of 65 years [1]. By 2040, the number of
individuals living with dementia in China will equal the combined
total of patients with dementia from high-income countries [3].
Given the current and projected prevalence of dementia in
China, the country must be prepared to address the impact of the
disease on affected patients, their caregivers, and the health care
system. Informal care costs (i.e., unpaid care provided by families
and others) account for more than half of the overall costsassociated with dementia care in rapidly developing countries such
as China (58% and 65% in lower- and middle-income countries,
respectively, vs. 40% in high-income countries) [1]. To develop and
implement effective strategies to reduce informal care costs and
alleviate associated burdens, policymakers and governmental insti-
tutions must have an understanding of the caregiver experience.
Studies investigating the caregiver experience in Chinese
culture have been reported. Most of these reports, however, have
focused on populations from Hong Kong or Taiwan while data
from mainland China are limited. To address this gap in data, a
multicenter, cross-sectional, hospital-based study that surveyed
caregivers of patients with dementia was carried out across all
seven regions of mainland China. Results reported here are the
first to characterize the diagnosis and awareness of dementia, as
well as the burden of dementia care as perceived by a cohort of
caregivers from mainland China.Patients and Methods
Study Design
This was a cross-sectional study. The study was approved by local
hospital ethics committees and completed in accordance withSociety for Pharmacoeconomics and Outcomes Research (ISPOR).
conflicts of interest with regard to the content of this article.
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Research Involving Human Subjects, adopted by the General
Assembly of the World Medical Association (1996). In addition,
the study was in accordance with the International Conference
on Harmonisation guidelines on Good Clinical Practice and
applicable local regulatory requirements and laws. All enrolled
patients and caregivers provided informed consent following
Chinese regulations. Patients were under supervision of their
legal guardian if necessary.
The study characterized demographics, cognitive clinical
status, and caregiver burden in patients with dementia
who presented at neurology clinics in China. The study had a
3-month open enrollment that started in September 2009 and
was completed in December 2009. To ensure coverage of all
regions and provinces, 48 tier-3 hospitals from all seven regions
of mainland China (Northern, Northeast, Northwest, Southwest,
Central, Eastern, and Southern) were selected. The number of
sites per province was proportional to the population of the
region, and hospitals were chosen by size, treatment tier, uni-
versity affiliation, and the presence of a neurology/dementia
center. Each participating neurology/dementia center had a
designated principal investigator who underwent a 2-day cen-
tralized training session that included standard diagnosis of
dementia and its subtypes, the dementia scales, patient/care-
giver interviews, and standard processes of data capture and
transfer in the study protocol. The principal investigators were
then responsible for delivering training to their staff.Patient Selection, Screening, and Diagnosis
Patients were selected by systematic screening of more than
500,000 male and female patients visiting participating neurol-
ogy/dementia clinics. Potential subjects were initially screened by
a health care professional for any cognitive complaints. Sus-
pected patients with dementia were referred to the lead neurol-
ogist at the study site, and then assessed for dementia by using
the validated and authorized Chinese version of the Mini-Mental
State Examination where low to very low scores correlate closely
with the presence of dementia [4]. The raw score was corrected
for educational attainment; the criterion for dementia diagnosis
was a Mini-Mental State Examination score of less than 19 for
patients who were illiterate or had no education, 22 or less for
patients with primary school education (education r6 years),
and 26 or less for those with middle school education or above
(education46 years). The study used a cut-point sensitivity of
93.2% for detecting dementia. Patients diagnosed with dementia
and their caregivers were then informed about the study and
given the option to participate.
All enrolled patients received a full evaluation of cognitive,
functional, and behavioral status using standard and validated
clinical measurements. Medical data collected included demo-
graphics, living habits and history, medical history, physical
exam, assessment of comorbidities, and laboratory tests that
included serum lipids and fasting glucose levels. Cognitive
evaluation included dementia severity, cognitive function, func-
tional status, assessment of symptoms, brain imaging by com-
puted tomography and magnetic resonance imaging for
dementia subtype diagnosis, and neuropsychological behavioral
disturbance assessment. Dementia was diagnosed on the basis of
The National Institute of Neurological and Communicative Dis-
orders and Stroke and Alzheimer’s Disease and Related Disorders
Association criteria and the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition criteria. Dementia subtypes were
also diagnosed according to accepted published criteria for VaD,
Lewy body dementia, Parkinson’s disease dementia, and mixed
dementia.Caregiver Assessment Interview
Caregivers who qualified for the study design (provided amount
and duration of care information), had intimate knowledge of
patient status, and accompanied enrolled patients with dementia
to the study site provided their consent to participate in the
Caregiver Assessment Interview on the patient and caregiver
profile, patient care, and caregiver experience. The Caregiver
Assessment Interview consisted of a series of questions about
the patient and a Clinical Dementia Rating (CDR) scale assess-
ment for the caregiver, both of which were completed by the
study physicians (investigators) with the information provided by
caregivers as informants. The patient questionnaire was
designed to obtain information on basic demographics, reasons
for current clinic presentation, pattern of symptoms, length of
time since symptom onset, current or previous treatment history,
treatment satisfaction and compliance, and costs related to
treatment and care. The CDR is a global measure of dementia
severity composed of six domains that assess cognition and
function: memory, orientation, judgment and problem solving,
community affairs, home and hobbies, and personal care. Impair-
ment in each category is rated on a five-point scale (none ¼ 0,
questionable ¼ 0.5, mild ¼ 1, moderate ¼ 2, and severe ¼ 3).
A physician with detailed knowledge of the patient completes the
scale. A structured interview is also part of the rating scale. The
CDR is given to both the patient and the caregiver [4].
Caregiver Burden Assessment
Caregiver burden was measured by using the Chinese version of
the validated Zarit Burden Interview (ZBI) [5] questionnaire. The
ZBI consists of 22 questions about the impact of the patient’s
disabilities on the caregivers’ life. For each item, caregivers
indicate how often they felt that way and responses are rated
from 0 to 4 (0 ¼ never, 1 ¼ rarely, 2 ¼ sometimes, 3 ¼ quite
frequently, and 4 ¼ nearly always). The ZBI was scored by adding
the numbered responses from individual items. Total score
ranged from 0 to 88, with higher scores indicating greater care-
giver distress [6]. Norms for the ZBI have not been computed, but
estimates of the degree of burden can be divided into four
categories: 0 to 20 (little or no burden), 21 to 40 (mild to moderate
burden), 41 to 60 (moderate to severe burden), and 61 to 88 (severe
burden) [6]. In this analysis, only questionnaires with responses
to 18 or more out of 22 questions (Z80% valid responses) were
used. For missing data (o4 missing questions), the average scores
from valid responses were rounded to the next integer and used
to fill in any missing fields.
Data Collection
Data were collected through digital or pen and paper report forms
in Chinese. All electronic and pen/paper data were sent to the
principal investigator of each study site for entry into the study
database by the research team.
Statistical Analysis
Data were summarized by using descriptive statistics using
statistical software SAS, version 9.0.Results
Demographics of Patients with Dementia
A total of 1425 caregivers who met the study qualifications
completed the study procedures with assistance from the site
investigator. About 50% of the study caregiver participants (719 of
1425) were from the eastern and northern regions (the former
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four hospitals in Beijing). More than 80% of the patients were
aged between 51 and 80 years, with a mean age of 67.6  12.8,
and 51.5% (n ¼ 734) were men (Table 1). Patients were roughly
evenly divided between three reported occupations: white-collar
worker (36.5%, n ¼ 520), laborer (29.5%, n ¼ 420), and farmer
(26.2%, n ¼ 373), with a minority reporting self-employment
(2.7%, n ¼ 39) or other (5.1%, n ¼ 73) as their profession. More
than three quarters of the patients had achieved some level of
education, with 28.1% (n ¼ 400) completing elementary school,
22.4% (n ¼ 319) completing junior high school, 14.9% (n ¼ 213)
completing high school or vocational school, and 13.2% (n ¼ 188)
completing college. Twenty-one percent were illiterate (n ¼ 299).
The majority of the patients resided in urban areas (62.9%), while
28.8% of the patients resided in rural areas. The remaining 8.3%
consisted of suburban dwellers (8.0%) and other (0.3%).
The overall severity of dementia among patients in this cohort
was mild to moderate (mean CDR of 1.67). Most patients with
dementia were diagnosed with AD (46.7%), followed by VaD
(28.7%), other dementia (11.6%), and mixed dementia (9.1%).Table 1 – Demographics and clinical characteristics
of patients among the study cohort.
Characteristic N ¼ 1425
Age (y), mean  SD 67.6  12.8
Gender, n (%)
Female 690 (48.4)
Male 734 (51.5)
Missing 1 (0.1)
Occupation, n (%)
White-collar 520 (36.5)
Laborer 420 (29.5)
Farmer 373 (26.2)
Other 73 (5.1)
Self-employed 39 (2.7)
Level of education, n (%)
Elementary school 400 (28.1)
Junior high 319 (22.4)
High school/vocational school 213 (14.9)
College/university 188 (13.2)
Illiterate 299 (21.0)
Other 6 (0.4)
Permanent residence, n (%)
Urban 896 (62.9)
Rural 411 (28.8)
Suburb 114 (8.0)
Other 4 (0.3)
CDR score, mean  SD 1.671  0.791
CDR score, n (%)
0.5 106 (7.4)
1 557 (39.1)
2 512 (35.9)
3 248 (17.4)
Type of dementia diagnosed, n (%)
AD 665 (46.7)
VaD 409 (28.7)
Mixed dementia 129 (9.1)
LBD 17 (1.2)
Parkinson’s disease dementia 28 (2.0)
Other types of dementia 166 (11.6)
Temporal lobe dementia 11 (0.8)
AD, Alzheimer disease; CDR, clinical dementia rating; LBD, Lewy
body dementia; VaD, vascular dementia.
 Unknown, missing, or incomplete data.The remaining cases of dementia (r2% each) consisted of
Parkinson’s disease dementia, Lewy body dementia, and tempo-
ral lobe dementia. Disease onset was slow for a majority of
patients (56.3%), followed by sudden (26.4%), insidious (14.5%),
and unknown (2.9%).Demographics of Caregivers of Patients with Dementia
Most caregivers were female (56.9%), and 47.3% had an educa-
tional level of high school or above (Table 2). The most common
caregiver relationship to the dementia patient was spouse
(51.9%), followed by son (33.2%) and daughter (9.2%). The majority
of family caregivers (57.4%) provided full-time care to the patient.Characterization of Dementia as Reported by Caregivers
The remainder of this report focuses on responses from 1387
caregivers (either family members or hired individuals who
provided care for patients with dementia). Results were also
divided into two categories: caregivers of patients who were
previously diagnosed with dementia (n ¼ 404) and caregivers of
patients who were newly diagnosed with dementia at the study
site (n ¼ 983). Table 3 shows the characteristics of the patient’s
dementia diagnosis as recalled by the caregiver. Among care-
givers of patients previously diagnosed with dementia, decline in
memory was the most often cited reason for prompting a visit to
the doctor (84.2%). The latency between the appearance of
dementia symptoms and seeing a neurologist was greater than
3 years (28.2%), less than 6 months (21.0%), 1 to 2 years (20.0%), 6
to 12 months (16.6%), and 2 to 3 years (13.6%). In the majority of
the cases (72%), the latency between the patient’s first doctor visit
and a confirmed diagnosis of dementia was less than 6 months.
Among caregivers of patients who were diagnosed with
dementia at the time of screening, 31.4% responded that the
latency between the appearance of dementia symptoms and
seeing a neurologist was less than 6 months followed by more
than 3 years (22.9%), 1 to 2 years (17.4%), 6 to 12 months (13.7%),
and 2 to 3 years (12.6%). Only 15.3% of the caregivers indicated
that the patient was completely aware of dementia symptoms at
the first doctor visit.Table 2 – Demographics of caregivers among the
study cohort.
Characteristic n (%)
Gender
Female 811 (56.9)
Male 603 (42.3)
Missing or unknown 11 (0.8)
Level of education
Elementary school 228 (16.0)
Junior high 427 (30.0)
High school/vocational school 380 (26.7)
College/university 293 (20.6)
Illiterate 84 (5.9)
Missing or unknown 13 (0.9)
Is the family member the full-time caregiver to the
patient?
Yes 818 (57.4)
No 592 (41.5)
Missing or unknown 15 (1.1)
 Temporary caregiver defined as a part-time worker, neighbor, or
volunteer.
Table 3 – Caregiver’s characterization of dementia
diagnosis.
Characteristic n (%)
Previous
diagnosis of
dementia
(n ¼ 404)
First
diagnosis of
dementia
(n ¼ 983)
Which dementia
symptoms prompted
you to see the doctor?
(multiple answers
allowed)
Decline in memory 340 (84.2) 733 (74.6)
Change in
temperament
140 (34.7) 283 (28.8)
Psychological
symptoms
92 (22.8) 188 (19.1)
Other symptoms or
illness
78 (19.3) 375 (38.1)
No details/do not
remember
15 (3.7) 33 (3.4)
Latency between
appearance of
dementia symptoms
and seeing a
neurologist
43 y 114 (28.2) 225 (22.9)
2–3 y 55 (13.6) 124 (12.6)
1–2 y 81 (20.0) 171 (17.4)
6–12 mo 67 (16.6) 135 (13.7)
o6 mo 85 (21.0) 309 (31.4)
Other 2 (0.5) 19 (1.9)
Latency between
patient’s first doctor
visit and confirmed
diagnosis of dementia
43 y 10 (2.5) NA
2–3 y 22 (5.4) NA
1–2 y 30 (7.4) NA
6–12 mo 46 (11.4) NA
o6 mo 291 (72.0) NA
Other 5 (1.2) NA
At the first doctor visit,
was the patient aware
of his or her dementia
symptoms?
Completely aware 57 (14.1) 150 (15.3)
Somewhat aware 162 (40.1) 467 (47.5)
Completely
unaware/denied
dementia
174 (43.1) 349 (35.5)
Other 11 (2.7) 17 (1.7)
 Unknown, missing, or incomplete data.
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Investigators also evaluated caregiver awareness of dementia.
Most caregivers of patients with previously diagnosed dementia
(62.9%) responded that they had a limited understanding of
dementia. More than half (54.7%) of the caregivers indicated that
the patient was taken to the doctor immediately following the
first signs or symptoms. The most common reasons for not
taking the patient immediately to the doctor were unawarenessof symptom severity (25.5%), unawareness of signs/symptoms of
dementia (24.5%), belief that the symptoms were part of the aging
process (18.8%), and being in denial of dementia (14.9%).
Among caregivers of patients who were diagnosed with
dementia at the time of screening, 42.8% reported taking the
patient to the doctor immediately after the first signs or symp-
toms. Compared with caregivers of patients with previously
diagnosed dementia, more caregivers reported being unaware
of the symptom severity (40.9%), unaware of the signs/symptoms
of dementia (36.9%), believing the symptoms were part of the
aging process (30.5%), and being in denial of dementia (24.4%).
Not enough data were collected regarding the caregivers’ per-
sonal understanding of dementia to draw a conclusion.
With regard to the patient’s awareness of his or her dementia
symptoms, only 14.1% of the caregivers reported that the patient was
completely aware of dementia symptoms at the first doctor visit.
Characterization of Dementia Care
More than three quarters (78.7%) of the caregivers had been
caring for the subjects with dementia for a year or more, while
10.8% had been caring for them for 3 months or less. Among
previously diagnosed patients with dementia, the most common
caring arrangements were patients living in their own home with
help from their family (51.7%) and living in a family member’s
home with help from a family member (24.0%). The most
common caring arrangements among patients diagnosed with
dementia at the time of this study were patients living in their
own home with help from their family (57.6%) and living in a
family member’s home with help from a family member (27.7%).
As expected, more previously diagnosed patients lived in hospi-
tal/nursing home/convalescent hospitals (10.9%) versus 1.5% of
those diagnosed with dementia at the time of the study. This may
reflect the longer disease course and progression of dementia in
the previously diagnosed patients. The mean total ZBI score was
higher for caregivers of patients who had previously been
diagnosed with dementia (28.34) compared with caregivers of
patients who were diagnosed with dementia at the time of the
screening (24.98).
Analysis of Caregiver Burden
Valid ZBI responses were obtained from 1381 caregivers and used
for analysis. Overall, 62% of the caregivers reported experiencing
a burden associated with dementia care (67% in caregivers of
previously diagnosed dementia vs. 60% in caregivers of patients
diagnosed with dementia at study screening). Most caregivers
reported mild to moderate burden (43%) or little to no burden
(38%) (Fig. 1). The total mean caregiver burden ZBI score was 26.6.
When caregiver burden was analyzed by age of caregiver (Fig. 2A),
gender of caregiver (Fig. 2B), level of education of caregiver,
dementia type (Fig. 3A), CDR (Fig. 3B), and duration of care, a
similar pattern was observed.Discussion
To date, this study represents the largest comprehensive screen-
ing of patients with dementia and their caregivers across main-
land China. Results were obtained from both urban and rural
patients/caregivers from all seven regions of China. In addition,
the study collected data from patients previously diagnosed with
dementia and those who were diagnosed at the time of enroll-
ment, allowing for a comparison of caregiver burden between
these groups.
AD and VaD account for a majority of dementia cases world-
wide, with AD being the more prevalent of the two. In 2005,
Zhang et al. [7] surveyed families of patients with dementia in
Fig. 1 – Overall caregiver burden questionnaire scores.
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VaD (yielding an AD to VaD ratio of 2.48:1). In two independent
population-based studies from China, the ratio of AD to VaD was
2.2:1 (n ¼ 87,761) and 3.2:1 (n ¼ 34,807) [8]. In other developing
countries such as China, the AD to VaD ratio can range from 1.2:1
up to 3.4:1 [8]. Among the cohort of patients with dementia
reported here, 46.7% were diagnosed with AD while 28.7% were
diagnosed with VaD, yielding an AD to VaD ratio of 1.63:1, which
is within the range of developing countries [8].
Diagnosis of Dementia
Although there is currently no consensus regarding the potential
benefits of early diagnosis and pharmacologic intervention in
dementia [9], some studies report a positive correlation. A French
study among 970 patients with VaD or AD reported that survival
was associated with the latency between first symptoms and first
visit: the shorter the latency, the longer the patients survived [10].
Although there is no evidence of a relationship between caregiver
burden and early diagnosis or treatment, early pharmacologic
intervention has been shown to improve cognitive and functional
outcomes in patients with mild and moderate AD [11]. Persistent
treatment with antidementia drugs has also been shown to have
a positive impact on disease progression across multiple cogni-
tive, functional, and global outcome measures in patients with
Alzheimer-type dementia [12].
In the current study, caregivers appeared to be proactive with
patient care. More than half (54.7%) of the caregivers of previ-
ously diagnosed patients with dementia and 42.8% of the care-
givers of patients diagnosed with dementia at screening
reportedly took the patient to the doctor immediately following
the first signs and symptoms. In addition, the diagnosis of
dementia was confirmed within 6 months of the first doctor visit
for the majority of patients with previously diagnosed dementia
(72%). In both groups, however, more than half of the caregivers
reported that the latency between the appearance of dementia
symptoms and seeing a neurologist was greater than 1 year. This
delay likely reflects the lack of specialists available to treat and
care for the overwhelming number of dementia (and elderly)
patients in China [2]. Inadequate access to specialists may delaydiagnosis and initiation of treatment interventions (pharmaco-
logic and/or behavioral).
Caregiver Awareness of Dementia
This study has a number of parallels with the Facing Dementia
Survey (FDS), one of the largest research surveys done on
dementia involving more than 2500 persons from six European
countries (France, Germany, Italy, Poland, Spain, and the United
Kingdom) [13]. The FDS included interviews with approximately
1200 members of the general public, 600 persons who served as
primary caregivers for a person with AD, and 96 persons with AD.
Caregiver interviews were either conducted face to face or via
telephone, and persons with dementia responded to a qualitative
interview that was designed to develop insight and direction
rather than quantitatively projectable measures [13].
A number of key messages from the FDS are similar to
findings in this study of Chinese dementia. First, AD and
dementia are difficult to recognize and diagnose. Both this study
and the FDS cited decline in memory as the most prevalent
reason for them to consult medical professionals. Caregivers
were slow to realize that the memory loss, confusion, and
personality changes were different from signs of normal aging.
In the present study, at least 45.3% of the caregivers did not take
the patient immediately to the doctor following the first symp-
toms. A prolonged period of inaction following the appearance of
symptoms was also evident in the FDS study, in which more than
1.5 years passed between the time symptoms were noticed and
the diagnosis of AD [13].
The lack of knowledge of dementia is one of the primary
reasons for the delay in diagnosis. Physicians from the FDS
responded that most members of the general population do not
know the difference between the early stages of AD and the signs
of normal aging and that most do not recognize the early signs of
the disease [13]. Other reasons cited for the diagnostic delay were
the belief that memory loss is a normal part of aging, the lack of
physician awareness of and experience with AD, and the obser-
vation that patients and families usually avoid unpleasant issues
or consciously ignore symptoms [13]. In this study, the majority
of caregivers said that they knew nothing about or had a limited
Fig. 2 – Caregiver burden questionnaire scores by (A) age and (B) gender.
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caregivers and members of the general public do not have
sufficient information about dementia and the benefits of treat-
ment and care.
Results reported here underscore the need for dementia
awareness, education, and support initiatives across mainland
China. According to the China Alzheimer’s Project, a voluntary
health organization in China, existing social support programs
(both nongovernmental and nonprofit) are small scale and offer
limited support for patients with dementia and their families [2].
Studies investigating the benefits of disease management pro-
grams that provide education and support to caregivers in
developing countries have been promising. The impact of suchprograms on caregiver burden has been demonstrated in neigh-
boring countries. The 10/66 Dementia Research Group has pub-
lished results from two studies that provided caregiver
interventions to families of patients with dementia in Russia
[14] and India [15]. In Russia, families in the caregiver interven-
tion group showed significant improvement in caregiver burden
compared with usual care, though there were no significant
differences in caregiver/patient quality of life or caregiver psy-
chological distress [14]. In India, caregiver intervention signifi-
cantly improved patient behavioral disturbances and caregiver
mental health [15].
More recently, a randomized controlled trial in families of
patients with dementia compared the effects of a dementia care
Fig. 3 – Caregiver burden questionnaire scores by (A) dementia type and (B) CDR score. CDR, Clinical Dementia Rating.
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month follow-up, the program produced significantly greater
improvements in patient symptoms and institutionalization
rates, as well as improvements in caregiver quality of life and
caregiver burden, compared with standard care [16].
Given the lack of dementia awareness in the present study, it
would behoove policymakers in China to invest in disease
management programs. From an economic standpoint, the costs
associated with such programs may be offset by the savings they
produce in patient hospitalization and caregiver burden. As
reported by the China Alzheimer’s Project, there is minimal
governmental and political support for dementia care asevidenced by low levels of support for public health education
and clinical research, or providing access to therapeutics. In
addition, there is currently a shortage of facilities and experi-
enced physicians specializing in treating patients with dementia
and elderly patients in general [2].
Caregiver Burden
The total mean score on the ZBI questionnaire in the caregivers
of patients previously diagnosed with dementia was 28.34 com-
pared with 24.98 for the caregivers of patients who had been
recently diagnosed in this study. The difference between the
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the progression of the disease.
The ZBI scores of both groups were lower than the mean score
of 31.0 established in a non-Asian study by Zarit et al. [6] but in
line with two validation studies of the Chinese version of the ZBI
that had mean ZBI scores of 24.6 and 24.4 [5,17]; these scores
were most comparable to the ZBI scores of caregivers of the
patients who were diagnosed with dementia at the study screen-
ing. Indeed, Chan and Chiu [17] noted that the patients with
dementia in their study were at a relatively early stage in the
course of their illness similar to the patients diagnosed with
dementia at study screening. In a Japanese study [18], the mean
total ZBI score for caregivers of patients with dementia was 28.6,
somewhat higher than in the present study, but lower than in
Zarit’s study of non-Asians [6].
A number of factors in addition to the ZBI should be consid-
ered when comparing caregiver burden in different populations.
It is important to consider caregiver characteristics such as age,
gender, educational level, ethnicity, and cultural values [17].
Studies have previously shown differences in caregiver burden
among different age groups and gender according to the relation-
ship with the patient [19,20]. Higher caregiver burdens have been
associated with younger age [21,22] and female gender [20]. In
addition, lower caregiver educational levels have been associated
with higher caregiver burdens [22,23]. In the present study,
however, no correlation was found between caregiver burden
and caregiver age, gender, or level of education.
Previous reports suggest that caregiver burden differs by type
of dementia and disease progression. In a study by Vetter et al.
[24], patients with early stage VaD imposed a greater burden on
caregivers than did patients with AD. As time progresses, this
relationship reverses, and caregivers of patients with AD report
experiencing greater burden than do caregivers of patients with
VaD [24]. Moreover, Vetter et al. [24] and Fuh et al. [23] reported
that caregiver burden scores increased with disease progression.
This was confirmed in a recent literature review on AD, in which
the factors most strongly correlated with caregiver burden were
the patient’s level of behavioral disturbance and psychiatric/
cognitive dysfunction, and the duration of dementia [25]. Inter-
estingly, the present study showed no correlation between the
type of dementia and the degree of burden, as all types seem to
impact most caregivers in a mild or moderate manner. Because
caregivers from both previously and newly diagnosed patients
cohorts were reported here, a possible explanation could be that
most patients were newly diagnosed with dementia. As a con-
sequence, the degree of burden reported in our study for demen-
tia showed a higher ‘‘mild to moderate’’ score rather than a severe
burden score.
Study Limitations
The present study has some limitations. First, subjects were
recruited from neurology clinics in tier-3 hospitals, who may
not be representative of patients and caregivers in the commun-
ity. While this was a large sample, the findings should not be
generalized to the whole Chinese population as the patients were
from either large urban or regional rural hospitals and may not be
representative of the population on the whole. While it would be
of interest, identifying regional differences in caregiver burden
are beyond the scope of this report. Second, the study had a
cross-sectional design, meaning that cause-and-effect relation-
ships cannot be established. Third, 277 (19.4%) caregiver
responses were categorized as ‘‘unknown’’ or ‘‘missing.’’ Last,
because the study was based on self-reporting by caregivers,
objective validation of reporting (e.g., level of awareness of
dementia and different dementia characteristics) was not pos-
sible. However, because of the sample size of the study, theresponses were valid for showing trends but should not be used
as strict quantitative measures of the Chinese population. Even
with these limitations, important information on the state of
dementia and caregiver distress was obtained.Conclusions
Dementia has significant emotional, social, and financial impact
on patients and their caregivers, regardless of demographics and
geography. This study highlights the growing issues of dementia
and the burdens caregivers experience across mainland China.
Dementia was found more often in patients living in urban areas
and affected both genders equally. The majority of patients in the
study had mild to moderate dementia, with AD as the diagnosis
in slightly less than half the patients followed by VaD in a quarter
of the patients. Dementia care was provided primarily by family
members, with more than half being spouses and one third of
caregivers being sons. Dementia caregiver burden assessed by
the ZBI was mild to moderate.
This study highlights the fact that caregivers of patients with
dementia face barriers to effective care that may be improved by
public education and public awareness campaigns that include
descriptions of dementia and normal aging. Further research is
needed on programs aimed at improving the psychosocial sup-
port of both persons with dementia and their family caregivers
across the many diverse Chinese populations.Acknowledgments
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